{"id":"https://openalex.org/W2590944526","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.2589","title":"Breast cancer: Role of tumor associated antigens and regulatory cells [CD4+CD25+] as targets of the Immune response elicited by an anti-progressive autologous hemoderivative vaccine","display_name":"Breast cancer: Role of tumor associated antigens and regulatory cells [CD4+CD25+] as targets of the Immune response elicited by an anti-progressive autologous hemoderivative vaccine","publication_year":2005,"publication_date":"2005-06-01","ids":{"openalex":"https://openalex.org/W2590944526","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.2589","mag":"2590944526"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2005.23.16_suppl.2589","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.2589","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2005.23.16_suppl.2589","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074450620","display_name":"E Garc\u00eda-Giralt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210145299","display_name":"Clinique Hartmann","ror":"https://ror.org/04z27mz17","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210145299"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"E. Garcia-Giralt","raw_affiliation_strings":["Ctr De Cancerologie Hartmann, Neuilly Sur Seine, France; PharmaBlood, North Miami Beach, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ctr De Cancerologie Hartmann, Neuilly Sur Seine, France; PharmaBlood, North Miami Beach, FL","institution_ids":["https://openalex.org/I4210145299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033238766","display_name":"Eduardo Lasalvia-Prisco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210145299","display_name":"Clinique Hartmann","ror":"https://ror.org/04z27mz17","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210145299"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"E. Lasalvia-Prisco","raw_affiliation_strings":["Ctr De Cancerologie Hartmann, Neuilly Sur Seine, France; PharmaBlood, North Miami Beach, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ctr De Cancerologie Hartmann, Neuilly Sur Seine, France; PharmaBlood, North Miami Beach, FL","institution_ids":["https://openalex.org/I4210145299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010760587","display_name":"Silvia Cucchi","orcid":"https://orcid.org/0009-0004-5934-3101","observed_orcids":["https://orcid.org/0009-0004-5934-3101"]},"institutions":[{"id":"https://openalex.org/I4210145299","display_name":"Clinique Hartmann","ror":"https://ror.org/04z27mz17","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210145299"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"S. Cucchi","raw_affiliation_strings":["Ctr De Cancerologie Hartmann, Neuilly Sur Seine, France; PharmaBlood, North Miami Beach, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ctr De Cancerologie Hartmann, Neuilly Sur Seine, France; PharmaBlood, North Miami Beach, FL","institution_ids":["https://openalex.org/I4210145299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056272011","display_name":"J. V\u00e1zquez","orcid":"https://orcid.org/0000-0002-3166-1632","observed_orcids":["https://orcid.org/0000-0002-3166-1632"]},"institutions":[{"id":"https://openalex.org/I4210145299","display_name":"Clinique Hartmann","ror":"https://ror.org/04z27mz17","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210145299"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J. V\u00e1zquez","raw_affiliation_strings":["Ctr De Cancerologie Hartmann, Neuilly Sur Seine, France; PharmaBlood, North Miami Beach, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ctr De Cancerologie Hartmann, Neuilly Sur Seine, France; PharmaBlood, North Miami Beach, FL","institution_ids":["https://openalex.org/I4210145299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042893333","display_name":"Eduardo Lasalvia-Galante","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210145299","display_name":"Clinique Hartmann","ror":"https://ror.org/04z27mz17","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210145299"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"E. Lasalvia-Galante","raw_affiliation_strings":["Ctr De Cancerologie Hartmann, Neuilly Sur Seine, France; PharmaBlood, North Miami Beach, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ctr De Cancerologie Hartmann, Neuilly Sur Seine, France; PharmaBlood, North Miami Beach, FL","institution_ids":["https://openalex.org/I4210145299"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011610134","display_name":"Wilson Golomar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210145299","display_name":"Clinique Hartmann","ror":"https://ror.org/04z27mz17","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210145299"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"W. Golomar","raw_affiliation_strings":["Ctr De Cancerologie Hartmann, Neuilly Sur Seine, France; PharmaBlood, North Miami Beach, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ctr De Cancerologie Hartmann, Neuilly Sur Seine, France; PharmaBlood, North Miami Beach, FL","institution_ids":["https://openalex.org/I4210145299"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210145299"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"23","issue":"16_suppl","first_page":"2589","last_page":"2589"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.953000009059906},{"id":"https://openalex.org/keywords/tumor-associated-antigens","display_name":"tumor-associated antigens","score":0.8270000219345093},{"id":"https://openalex.org/keywords/cea","display_name":"CEA","score":0.6899999976158142},{"id":"https://openalex.org/keywords/ca-15-3","display_name":"CA15-3","score":0.9919999837875366},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.8109999895095825},{"id":"https://openalex.org/keywords/cd4-cd25-regulatory-t-cells","display_name":"CD4+CD25+ T cells","score":0.9039999842643738},{"id":"https://openalex.org/keywords/lymphocyte-proliferation","display_name":"lymphocyte proliferation","score":0.6899999976158142},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.5690000057220459},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9369999766349792},{"id":"https://openalex.org/keywords/hormone-resistant-breast-cancer","display_name":"hormone-resistant breast cancer","score":0.5379999876022339},{"id":"https://openalex.org/keywords/stable-disease","display_name":"stable disease","score":0.6309999823570251},{"id":"https://openalex.org/keywords/vaccine-response","display_name":"vaccine response","score":0.4020000100135803}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8774298429489136},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6403070688247681},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5774211287498474},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.5572498440742493},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5508806109428406},{"id":"https://openalex.org/C79484868","wikidata":"https://www.wikidata.org/wiki/Q5971673","display_name":"IL-2 receptor","level":4,"score":0.54475998878479},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.527062177658081},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5265510678291321},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.4995412826538086},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.46207502484321594},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4543551206588745},{"id":"https://openalex.org/C2779727006","wikidata":"https://www.wikidata.org/wiki/Q426188","display_name":"FOXP3","level":3,"score":0.4529728293418884},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4270368814468384},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.42481765151023865},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.42155998945236206},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4011591672897339},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3873286247253418},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.24265331029891968},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2005.23.16_suppl.2589","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.2589","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2005.23.16_suppl.2589","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4246651542","https://openalex.org/W2589973702","https://openalex.org/W2031066617","https://openalex.org/W2333620569","https://openalex.org/W2146300308","https://openalex.org/W2071033172","https://openalex.org/W2362251282","https://openalex.org/W2099515509","https://openalex.org/W1964763671","https://openalex.org/W2086923392"],"abstract_inverted_index":{"2589":[0],"Background:":[1],"In":[2,160],"advanced":[3],"cancer":[4,44,54],"from":[5,135,217,233,261],"different":[6],"primary":[7],"tumors,":[8],"our":[9],"team":[10],"(E.":[11],"Lasalvia-Prisco":[12],"et":[13],"al,":[14],"Cancer":[15],"Biology":[16],"&":[17],"Therapy,":[18],"2003*;":[19],"ASCO":[20,22],"2003,":[21],"2004)":[23],"has":[24],"reported":[25],"anti-tumoral":[26,287],"effect":[27,241,250],"of":[28,289],"an":[29,35,254,286],"immunotherapy":[30],"procedure":[31],"using":[32,109],"as":[33,74,86,105,115,119,132],"immunogen":[34],"autologous":[36,128],"hemoderivative":[37],"(AHD).":[38],"We":[39],"explored":[40],"in":[41,173,246],"a":[42],"breast":[43,53],"population":[45],"the":[46,161,174,179,194,243,265],"immunological":[47],"mechanisms":[48],"involved.":[49],"Methods:":[50],"Patients.-":[51],"Metastatic":[52],"patients":[55,152,165,185],"(n=":[56],"121),":[57],"hormone/chemotherapy":[58],"resistant,":[59],"high":[60],"CEA/CA":[61],"15\u20133":[62,213],"plasma":[63],"levels,":[64],"PS<3":[65],"and":[66,76,97,125,145,178,186,215,226,269],"documented":[67],"progressive":[68,87],"disease":[69,88,92],"were":[70,153,158,183,190,207],"2-group":[71],"randomized:":[72],"AHD-vaccinated":[73],"reported*":[75],"controls.":[77],"Assessment.-":[78],"Clinical":[79],"response:":[80,95],"monthly":[81],"assessed":[82],"according":[83],"to":[84,264],"RECIST":[85],"(PD)":[89],"or":[90,298,301],"stable":[91],"(SD).":[93],"Immune":[94],"pre":[96],"20-day":[98],"post":[99],"treatment,":[100,193],"Lymphocyte":[101],"Proliferation":[102],"Assay":[103],"measured":[104],"thymidine-H3":[106],"incorporation":[107],"(LPA)":[108],"peripheral":[110],"blood":[111,266],"mononuclear":[112],"cells":[113,117,219,235,263,274],"(PBMC)":[114],"responder":[116],"and,":[118],"challengers:":[120],"CEA,":[121,211],"CA":[122,212],"15\u20133,":[123],"AHD":[124,133,238,293],"2":[126,136],"other":[127],"hemoderivatives":[129],"(AH)":[130],"obtained":[131],"but":[134,276],"lymphocyte":[137],"populations":[138],"(Wan":[139],"Fal":[140],"Ng":[141],"preparation":[142],"method):":[143],"[CD4+CD25+]":[144,218,275],"[CD4+CD25-].":[146],"Results:":[147],"After":[148],"8-month":[149],"follow-up,":[150],"101":[151],"evaluated":[154],"(50/51":[155],"control/treated).":[156],"Groups":[157],"comparable.":[159],"treated":[162],"group,":[163],"25/51":[164,247],"reached":[166],"SD":[167],"status,":[168],"significantly":[169],"higher":[170],"(p<0.001)":[171,214],"than":[172],"controls":[175],"(1/50":[176],"pts),":[177],"responders":[180,195],"(reaching":[181],"SD)":[182],"25":[184],"non-responders":[187],"(persisting":[188],"PD)":[189],"26.":[191],"Post":[192],"have":[196],"LPA":[197,221],"positive":[198],"(challenged":[199],">":[200],"4":[201],"x":[202],"control)":[203],"when":[204,229],"their":[205],"PBMCs":[206],"challenged":[208],"with":[209,253,285],"AHD,":[210],"AH":[216,232],"(p<002).":[220],"was":[222,231,251],"negative":[223],"before":[224],"treatment":[225,228],"after":[227],"challenger":[230],"[CD4+CD25-]":[234,279],"(p>0.5).":[236],"Conclusions:":[237],"induced":[239],"anti-progressive":[240],"upon":[242],"tumor":[244],"growth":[245],"patients.":[248],"This":[249],"associated":[252],"immune":[255],"response":[256],"poli-targeted":[257],"against":[258,271,278],"molecules":[259],"released":[260],"malignant":[262],"(CEA/CA":[267],"15\u20133)":[268],"also":[270],"regulatory":[272],"(tolerance)":[273],"not":[277],"cells.":[280],"These":[281],"facts":[282],"are":[283],"compatible":[284],"mechanism":[288],"autoimmunity":[290],"elicited":[291],"by":[292],"vaccine.":[294],"Author":[295],"Disclosure":[296],"Employment":[297],"Leadership":[299],"Consultant":[300],"Advisory":[302],"Role":[303],"Stock":[304],"Ownership":[305],"Honoraria":[306],"Research":[307],"Funding":[308],"Expert":[309],"Testimony":[310],"Other":[311],"Remuneration":[312],"PharmaBlood":[313]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2017-03-03T00:00:00"}